Lutetium-177 iPSMA: A Game-Changer in Prostate Cancer Therapy
Lutetium-177 iPSMA revolutionises prostate cancer treatment, delivering targeted beta radiation to metastatic cells with precision and minimal side effects.
Lutetium-177 iPSMA: A Game-Changer in Prostate Cancer Therapy Read Post »